All about ebola virus

Strategic highlights ? continuing to deliver on strategic and operational priorities Maintaining leadership in programmable networks, with new 5G Advanced software launched in October.Growing interest in network APIs, with financial fraud protection...

Order intake SEK 31,562 million (30,062)Order intake, at fixed exchange rates, increased by 5%Revenues SEK 32,151 million (31,816)Revenue growth, at fixed exchange rates increased by 1%Adjusted EBITA SEK 6,288 million (6,211)Adjusted EBITA margin...

Quarter 4, 2024 Net sales increased 3.2% to SEK 37,805m (36,625)Organic growth amounted to 3.9%, of which volume accounted for 1.7% and price/mix 2.2%. Excluding restructuring, organic growth increased 4.9%.EBITA decreased 1% to SEK 4,585m...

According to the latest study from BCC Research, "Global Private 5G Network Market" is projected to reach $22.2 billion by the end of 2029, at a CAGR of 46.8% for the forecast period of 2024-2029. Private 5G networks cover hardware, software, and...

After 14 years with the Group, and almost ten years as president and CEO, Magnus Groth has today informed the Board of Directors of Essity Aktiebolag (publ) that he has decided to step down as CEO and from the Board during 2025.  A recruitment...

SKF's Nomination Committee proposes Mats Rahmström as a new board member in AB SKF. Mats Rahmström was the President and CEO, as well as a member of the Board of Directors of Atlas Copco Group up until April 2024 and has held several senior...

Between January 13, 2025, and January 17, 2025, Essity Aktiebolag (publ) repurchased a total of 270,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors. The share purchase is...

Integral Molecular, a leading biotechnology company in Philadelphia, is honored to announce its recognition as an Employer of Choice by the City of Philadelphia's Department of Commerce, Office of Workforce Solutions, in conjunction with the...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the Company will deliver a...

SKF will publish its Q4 results for 2024 on 31 January at approximately 07:00 (CET). Investors, analysts and media are invited to join a webcast, which will be held in English, at 08:00 (CET). To join the webcast, please login at least 10 minutes...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced an interim update on the open-label,...

Since the COVID-19 pandemic, mRNA vaccines have been recognized as the most important platform for infectious disease prevention and continue to be utilized across various fields. However, concerns remain about the limitations of the technology,...

NanoViricides, Inc. (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced today that it is presenting at Biotech Showcase™ 2025 in San Fransisco,...

Between January 7, 2025, and January 10, 2025, Essity Aktiebolag (publ) repurchased a total of 216,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors. The share purchase is...

Kindeva Drug Delivery, a global CDMO and drug delivery expert, and Emervax, a developer of a proprietary circular RNA-based vaccine platform (emxRNATM), today announced an exclusive partnership to co-develop a game-changing solution for the...

INOVIO , a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today highlighted anticipated milestones for 2025 and key...

Dr. Anil Diwan, President of NanoViricides, Inc. (the "Company"), comments on the many viruses that could cause pandemics that are going around already.This season, two different genotypes of H5N1 bird flu, namely (a) the severe and lethal...

Between December 30, 2024, and January 3, 2025, Essity Aktiebolag (publ) repurchased a total of 162,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors. The share purchase is...

Between December 23, 2024, and December 27, 2024, Essity Aktiebolag (publ) repurchased a total of 108,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors. The share purchase is...

Due to a conversion of shares from Series A to Series B in accordance with AB SKF's Articles of Association, the Company confirms the following. As per 30 December 2024 there are a total of 455,351,068 number of shares in AB SKF, out of which...

NanoViricides, Inc. (the "Company"), says that its broad-spectrum antiviral drug candidate NV-387 is the best weapon to fight a potential bird flu pandemic because the mercurial H5N1 Influenza A virus would not be able to escape the...

Between December 16, 2024, and December 20, 2024, Essity Aktiebolag (publ) repurchased a total of 270,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors. The share purchase is...

Aethlon Medical, Inc. , a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today provided a statement of its investigational medical device with respect to H5N1 avian influenza "Bird...

SKF has launched a generative artificial intelligence (Gen AI) enabled tool named SKF Product assistant to assist customers with accessing the right technical information more efficiently. Available on the SKF website, the AI-enabled tool responds to...

The CDC Foundation today announced the appointment of two new members to its board of directors: Brian Gott, chief innovation officer for the Entertainment Industry Foundation (EIF), and Donald Warne, MD, MPH, co-director of the Center for Indigenous...

SKF has been awarded a Platinum Medal by EcoVadis, one of the most trusted providers of sustainability ratings for use in supply chains, for the fifth consecutive year. The Platinum Medal is the highest level of recognition from EcoVadis and it...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has opened patient enrollment...

Between December 9, 2024, and December 13, 2024, Essity Aktiebolag (publ) repurchased a total of 270,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors. The share purchase is...

IAVI, a nonprofit scientific research organization dedicated to addressing urgent global health challenges including HIV, tuberculosis, and emerging infectious diseases (EIDs), and the Institut Pasteur de Dakar (IPD), a non-profit foundation focused...

Today, an extraordinary general meeting has been held in SciBase Holding AB (publ) ("SciBase" or the "Company"). The general meeting resolved in accordance with the proposals presented in the notice to convene the meeting (which is available on the...